The HR estimate for T2DM and survival among all invasive breast cancers (HR = 1.10) was higher than that for either ER-subtype individually (ER-positive: HR = 1.09; ER-negative: HR = 1.09). The gene discussed is ESR1; the disease is type 2 diabetes mellitus.